4[4]Fong DS,Aiello L,Gardner TW,et al.Diabetic Retinopathy.Diabetes Care 2003;26(1):226-9
5[5]Service FJ,O' Brien PC.The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial.Diabetologia 2001;44 (10):1215-20
6[6]White NH,Cleary PA,Dahms W,et al.Beneficial effects of intensive therapy of diabetes during adolescence:outcomes after the conclusion of the Diabetes Control and Complications Trial(DCCT).J Pediatr 2001;139(6):804-12
7[7]Stratton IM,Kohner EM,Aldington SJ.et al.UKPDS 50:risk factors for incidence and progression of retinopathy in Type Ⅱ diabetes over 6 years from diagnosis.Diabetologia 2001;44(2):156-63
8[8]Porta M,Sjoelie AK,Chaturvedi N,et al.Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study.Diabetologia 2001;44 (12):2203-9
9[9]Kullberg CE,Abrahamsson M,Arnqvist HJ,et al.P.revalence of retinopathy differs with age at onset of diabetes in a population of patients with Type 1 diabetes.Diabet Med 2002;19(11):924-31
10[10]Schalkwijk CG,Chaturvedi N,Twaafhoven H,et al.Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients.Eur J Clin Invest 2002;32 (7):500-6
